A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata

Clinical trial NCT07772492 · RECRUITING

Trial details

NCT number: NCT07772492
Sponsor: AbbVie
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Severe Alopecia Areata

Start date: 2026-08-30
Primary completion: 2032-03-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.